Emyria LtdASX: EMD

Emyria Presentation at FDA Hearing

· Issued by Emyria Ltd via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/emyria-presentation-at-fda-hearing

Emyria ASX Announcement | 16 September 2026 1 ASX RELEASE. 16 September 2026 Emyria Presents to U.S FDA At Psychedelics Medicine Hearing Executive Chairman outlines Emyria’s Australian treatment-delivery experience directly to U.S. regulators Emyria Limited (ASX: EMD)...

View Attachment

6ix hasn’t read this filing yet.

Emyria Ltd on 6ix

Story so far

Earlier from Emyria

Later from Emyria

All Emyria news releases